342 BLEEDING AND THROMBOEMBOLISM ASSOCIATED WITH ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER –A NATIONWIDE MULTICENTER STUDY IN JAPAN–
Waku Hatta,Yosuke Tsuji,Sho Shiroma,Naomi Kakushima,Shu Hoteya,Hisashi Doyama,Yasuaki Nagami,Takuto Hikichi,Masakuni Kobayashi,Yoshinori Morita,Tetsuya Sumiyoshi,Mikitaka Iguchi,Hideomi Tomida,Takuya Inoue,Tomoyuki Koike,Tatsuya Mikami,Kenkei Hasatani,Atsushi Goto,Tomoaki Matsumura,Hiroko Nebiki,Dai Nakamatsu,Ken Ohnita,Haruhisa Suzuki,Hiroya Ueyama,Yoshito Hayashi,Mitsushige Sugimoto,Shinjiro Yamaguchi,Tomoki Michida,Tomoyuki Yada,Yoshiro Asahina,Toshiaki Narasaka,Shiko Kuribayashi,Shu Kiyotoki,Katsuhiro Mabe,Mitsuhiro Fujishiro,Atsushi Masamune
DOI: https://doi.org/10.1016/j.gie.2019.04.046
IF: 10.396
2019-01-01
Gastrointestinal Endoscopy
Abstract:Endoscopic submucosal dissection (ESD) is a well-established treatment for early gastric cancer (EGC). Post-operative bleeding is one of the most frequent adverse events associated with the ESD procedure, and a previous meta-analysis showed that the pooled post-operative bleeding was 5.1%. However, the timing of post-ESD bleeding in patients with/without antithrombotics has not been fully understood. Furthermore, there is no data regarding thromboembolism associated with ESD for EGC. In this nationwide multicenter study, we aimed to reveal the timing of bleeding and thromboembolism associated with ESD for EGC.